DACH1 inhibits the proliferation and migration of papillary thyroid carcinoma. (13th December 2022)

• Record Type: Journal Article
• Authors: Liang, Shengru; Xu, Qian; Liu, Boyun; Hu, Ruofan; Lai, Jingbo; Wang, Wei; Yu, Xinwen; Gou, Jiakun; Wang, Li; Chen, Yanyan; Ji, Qiuhe; Zhou, Jie
• Is Part Of: Cell biology international. Volume 47:Number 3(2023)
• Page Start: 612
• Page End: 621
• Publication Date: 2022-12-13
• Subjects: DACH1 -- chemokines -- migration -- papillary thyroid carcinoma -- proliferation; Cytology -- Periodicals; Cells -- Periodicals; 571.605
• DOI: 10.1002/cbin.11961
• Languages: English
• ISSNs: 1065-6995

Abstract

Abstract: DACH1 is an important component of the retinal determinate gene network (RDGN), which regulates the expression of target genes by directly binding or interacting with other factors. DACH1 shows inhibitory effects in most tumors, but its role in papillary thyroid carcinoma is unclear and warrants further investigation. We assessed the expression of DACH1 in different tissues and correlation with immune infiltration by The Cancer Genome Atlas (TCGA) and Tumor Immune Estimation Resource (TIMMER2.0 databases). The effects of DACH1 on the proliferation and migration of TPC‐1 and Bcpap cells were assessed by cell viability assay, colony formation assay, wound healing assay, transwell migration assay, and flow cytometry. Finally, the effects of DACH1 on CXCL8, CXCL10, and CXCL12 expression in Nthy‐ori‐3‐1, TPC‐1 and Bcpap cells were assessed by enzyme‐linked immunosorbent assay kit and real‐time polymerase chain reaction, respectively. The results showed that DACH1 was differentially expressed in different tumors and tissues. Basal expression of DACH1 was lower in thyroid and papillary thyroid carcinoma than in other normal tissues and corresponding tumors, and positively correlated with CD8 + T cell infiltration. In Nthy‐ori‐3‐1, TPC‐1 and Bcpap cells, overexpression of DACH1 inhibited cell migration and proliferation, and the opposite results was obtained by knocking down DACH1 using small interfering RNA. We also demonstrated that DACH1 regulated chemokines CXCL8, CXCL10, and CXCL12, thereby modulating tumor immunity.